Agios Pharmaceuticals market cap AGIO

Share price times shares outstanding: what the whole company sells for, since 2013.

Agios Pharmaceuticals is worth $2.2B at the close on Oct 23, 2026, at $37.00 a share.

That is down 12% over the last year and down 20% over five years.

Its highest close in our data was $5.6B in Jun 2018.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$2.2B	$1.5B	$2.5B	+35%
2025	$1.6B	$1.4B	$2.5B	−14%
2024	$1.9B	$1.2B	$3.5B	+53%
2023	$1.2B	$1.1B	$1.7B	−19%
2022	$1.5B	$984.6M	$1.9B	−14%
2021	$1.8B	$1.6B	$3.9B	−41%
2020	$3B	$2.3B	$3.8B	+5%
2019	$2.9B	$1.9B	$4B	+8%
2018	$2.6B	$2.5B	$5.6B	−5%
2017	$2.8B	$1.7B	$3.5B	+59%
2016	$1.8B	$1.4B	$2.7B	−28%
2015	$2.4B	$2B	$4.6B	−38%
2014	$4B	$716M	$4.1B	+420%
2013	$763.7M	$547.1M	$1B	n/a

Companies in Drug Manufacturers - General nearest Agios Pharmaceuticals' size, closest first, today.

Company	Market cap
AGIOAgios Pharmaceuticals	$2.2B
PBHPrestige Consumer Healthcare	$2.3B
HRMYHarmony Biosciences	$2.1B
NRIXNurix Therapeutics	$2.8B
ANIPANI Pharmaceuticals	$1.7B
PAHCPhibro Animal Health	$1.6B
ANABAnaptysbio	$1.5B
PCRXPacira BioSciences	$1.5B
OGNOrganon	$3.6B
LQDALiquidia	$3.8B
ARQTArcutis Biotherapeutics	$3.9B
Peer median	$2.2B